Search results
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 2 days agoWhat: In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from ...
...from Pivotal Phase 2 TRUST-I Study of Taletrectinib（ROS1 Inhibitor) are Published in the JCO and...
The Grass Valley Union· 4 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
Liquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
Investor's Business Daily· 2 days agoOn Friday, U.S. District Court Judge Richard Andrews denied United Therapeutics' request for a...
Two Florida researchers discuss the health impact of vaping
WUSF 89.7· 21 hours agoVaping has surged in popularity, even as overall smoking rates have declined. Among teens who use tobacco products, e-cigarettes are more popular than smoking traditional cigarettes or other ...
Should people eat insects instead of meat? Experts explain the benefits of bugs
ABC News· 8 hours ago"Because of our heavy European cultural influence, most Americans shun the idea of eating insects,"...
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression - BrainsWay (NASDAQ:BWAY)
Benzinga· 2 days ago(NASDAQ & TASE: BWAY) ("BrainsWay" or the "Company"), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that the US Food ...
Clinical trial leads to FDA approved treatment for peripheral artery disease
MinnPost· 1 day agoPeripheral artery disease or PAD, said Jennifer Jones-McMeans, Ph.D., divisional vice president of...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 6 days agoU.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND SETS NEW ACTION DATE PR Newswire TOKYO, May 30, 2024 If approved, the investigational ...
CARVYKTI® (ciltacabtagene autoleucel) significantly improved progression-free survival and deepened...
Valley City Times Record· 2 days agoJohnson & Johnson announced today results from a subgroup analysis of the Phase 3 CARTITUDE-4 study. Data from the CARTITUDE-4 study supported the recent U.S. FDA approval of CARVYKTI®, the ...
Liquidia Rises 12% In Pre-market On Favorable Court Ruling For Yutrepia
RTT News· 2 days agoTherapeutics' request to block the launch of Liquidia's Yutrepia inhalation powder to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). "The ...
